Nutrition Care in Patients Living with Chronic Pain
Launched by LINKOEPING UNIVERSITY · Feb 17, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile app called Diet4painrelief, which aims to help people living with chronic pain improve their nutrition. The app will assess participants' eating habits and nutritional status and provide a personalized program to promote healthier dietary choices. The trial will include 20 patients who are overweight or have obesity, all of whom are experiencing ongoing pain that affects their daily lives. To participate, individuals need to have a Body Mass Index (BMI) of 25 or higher, agree to join the pain rehabilitation program, and have access to the internet through a mobile phone.
Participants can expect to complete dietary recordings and follow a tailored nutrition plan over the course of the study. Their progress will be monitored through questionnaires about their pain, quality of life, and physical abilities at three points: at the start of the program, right after completing it, and again 12 months later. Additionally, blood samples will be taken to gather more information about their health. It's important to note that certain health conditions, like pregnancy or severe psychiatric issues, may prevent individuals from participating in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self reported Body Mass Index (BMI)\>=25;
- • Written consent to participate and attend to the pain rehabilitation program due to disabling chronic pain (on sick leave or experiencing major interference in daily life due to chronic pain)
- • Agreement not to participate in other parallel treatments for weight reduction
- • Not currently using medications of weight reduction
- • Available to get access to internet via own mobile/cellphone.
- Exclusion Criteria:
- • Health conditions such as pregnancy, active metabolic disease, rheumatoid arthritis, and serious psychiatric disease (investigator's judgement, eg, psychosis or suicidal ideation);
- • Coagulation disorders with predisposition to bleeding, medication with anticoagulants (low- dose aspirin is permitted);
- • hypersensitivity to anaesthetic
- • Difficulties in understanding the Swedish language.
About Linkoeping University
Linköping University is a leading academic institution in Sweden, renowned for its innovative research and commitment to advancing medical science. With a strong emphasis on interdisciplinary collaboration, the university facilitates cutting-edge clinical trials aimed at improving patient outcomes and enhancing healthcare delivery. Linköping University’s research initiatives are supported by state-of-the-art facilities and a robust network of partnerships with healthcare providers, industry stakeholders, and regulatory bodies, ensuring rigorous methodologies and ethical standards in all clinical investigations. Through its dedication to research excellence, Linköping University plays a pivotal role in translating scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Linköping, östergötlands Län, Sweden
Linköping, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported